Gerald V. Doyle

15.7k total citations · 8 hit papers
39 papers, 12.4k citations indexed

About

Gerald V. Doyle is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerald V. Doyle has authored 39 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 23 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerald V. Doyle's work include Cancer Cells and Metastasis (35 papers), Cancer Genomics and Diagnostics (19 papers) and Prostate Cancer Treatment and Research (5 papers). Gerald V. Doyle is often cited by papers focused on Cancer Cells and Metastasis (35 papers), Cancer Genomics and Diagnostics (19 papers) and Prostate Cancer Treatment and Research (5 papers). Gerald V. Doyle collaborates with scholars based in United States, Netherlands and United Kingdom. Gerald V. Doyle's co-authors include Leon W.M.M. Terstappen, Michael Craig Miller, Daniel F. Hayes, Massimo Cristofanilli, Jeri Matera, G. Thomas Budd, W. Jeffrey Allard, Alison Stopeck, Matthew J. Ellis and James M. Reuben and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Gerald V. Doyle

39 papers receiving 12.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

2004 3.5k citations Massimo Cristofanilli, G. Thomas Budd et al. New England Journal of Medicine profile →
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

2008 1.7k citations Johann S. de Bono, Howard I. Scher et al. Clinical Cancer Research profile →
Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

2008 1.5k citations Steven J. Cohen, Cornelis J.A. Punt et al. Journal of Clinical Oncology profile →
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

2005 857 citations Massimo Cristofanilli, Daniel F. Hayes et al. Journal of Clinical Oncology profile →
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival

2006 808 citations Daniel F. Hayes, Massimo Cristofanilli et al. Clinical Cancer Research profile →
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

2009 609 citations Michael Craig Miller, Gerald V. Doyle et al. profile →
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer

2006 594 citations G. Thomas Budd, Massimo Cristofanilli et al. Clinical Cancer Research profile →
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

2014 482 citations Jeffrey B. Smerage, William E. Barlow et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald V. Doyle United States	24	9.6k	6.8k	3.7k	2.9k	2.5k	39	12.4k
Catherine Alix‐Panabières France	48	7.6k 0.8×	6.8k 1.0×	2.7k 0.7×	2.4k 0.8×	3.8k 1.6×	152	11.8k
W. Jeffrey Allard United States	25	6.4k 0.7×	4.5k 0.7×	2.9k 0.8×	2.1k 0.7×	3.3k 1.4×	50	11.8k
Jeri Matera United States	9	6.3k 0.7×	4.3k 0.6×	2.2k 0.6×	2.1k 0.7×	1.6k 0.7×	16	8.1k
Eunice L. Kwak United States	43	7.1k 0.7×	2.8k 0.4×	5.3k 1.4×	1.9k 0.7×	4.0k 1.6×	132	12.6k
Jean‐Yves Pierga France	59	8.0k 0.8×	6.3k 0.9×	3.5k 0.9×	986 0.3×	2.3k 0.9×	331	12.0k
Brian W. Brannigan United States	18	9.5k 1.0×	4.3k 0.6×	9.1k 2.4×	844 0.3×	6.0k 2.5×	25	15.4k
François‐Clément Bidard France	47	5.0k 0.5×	4.5k 0.7×	2.4k 0.6×	945 0.3×	2.0k 0.8×	220	7.8k
Sunitha Nagrath United States	39	4.6k 0.5×	3.2k 0.5×	1.5k 0.4×	4.5k 1.5×	3.0k 1.2×	107	9.4k
Emmanuelle di Tomaso United States	41	4.2k 0.4×	2.8k 0.4×	1.8k 0.5×	1.4k 0.5×	5.2k 2.1×	90	11.1k
F. Jänicke Germany	54	5.5k 0.6×	6.2k 0.9×	1.6k 0.4×	695 0.2×	3.1k 1.3×	183	11.3k

Countries citing papers authored by Gerald V. Doyle

Since Specialization

Citations

This map shows the geographic impact of Gerald V. Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald V. Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald V. Doyle more than expected).

Fields of papers citing papers by Gerald V. Doyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald V. Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald V. Doyle. The network helps show where Gerald V. Doyle may publish in the future.

Co-authorship network of co-authors of Gerald V. Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald V. Doyle. A scholar is included among the top collaborators of Gerald V. Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald V. Doyle. Gerald V. Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paoletti, Costanza, Jieling Miao, Elizabeth P. Darga, et al.. (2019). Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study. Clinical Cancer Research. 25(20). 6089–6097. 57 indexed citations

Smerage, Jeffrey B., G. Thomas Budd, Gerald V. Doyle, et al.. (2013). Monitoring apoptosis and Bcl‐2 on circulating tumor cells in patients with metastatic breast cancer. Molecular Oncology. 7(3). 680–692. 81 indexed citations

Strijbos, Michiel, Jan W. Gratama, Paul Schmitz, et al.. (2010). Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel. European Journal of Cancer. 46(11). 2027–2035. 42 indexed citations

Connelly, Mark C., Yixin Wang, Gerald V. Doyle, Leon W.M.M. Terstappen, & Robert McCormack. (2009). Re: Anti–Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells. JNCI Journal of the National Cancer Institute. 101(12). 895–895. 9 indexed citations

Connelly, Mark C., et al.. (2009). Commentary the molecular characterization of 19 breast cancer cell lines by Sieuwerts et al.. JNCI Journal of the National Cancer Institute. 101. 895. 5 indexed citations

Cohen, Steven J., Cornelis J.A. Punt, Nicholas Iannotti, et al.. (2009). Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Annals of Oncology. 20(7). 1223–1229. 418 indexed citations

Bono, Johann S. de, Christopher Parker, Howard I. Scher, et al.. (2009). Quantitative Analysis of Circulating Tumor Cells as a Survival Predictor in Metastatic Castration–Resistant Prostate Cancer: Missing Parts in a Superb Study. Clinical Cancer Research. 15(4). 1504–1505. 4 indexed citations

Giorgi, Ugo De, V. Valero, Eric Rohren, et al.. (2009). Circulating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer. Annals of Oncology. 21(1). 33–39. 74 indexed citations

Bono, Johann S. de, Howard I. Scher, Bruce Montgomery, et al.. (2008). Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 14(19). 6302–6309. 1744 indexed citations breakdown →

10.

Cohen, Steven J., Cornelis J.A. Punt, Nicholas Iannotti, et al.. (2008). Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(19). 3213–3221. 1473 indexed citations breakdown →

11.

Doyle, Gerald V., G. T. Budd, Madeline Repollet, et al.. (2008). Detection of Bcl-2 and apoptosis in circulating tumor cells during treatment of metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 11016–11016. 2 indexed citations

12.

Shaffer, David R., Margaret Leversha, Daniel C. Danila, et al.. (2007). Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer. Clinical Cancer Research. 13(7). 2023–2029. 284 indexed citations

13.

Smirnov, Denis A., Bradley W. Foulk, Gerald V. Doyle, et al.. (2006). Global Gene Expression Profiling of Circulating Endothelial Cells in Patients with Metastatic Carcinomas. Cancer Research. 66(6). 2918–2922. 73 indexed citations

14.

Smirnov, Denis A., Daniel R. Zweitzig, Bradley W. Foulk, et al.. (2005). Global Gene Expression Profiling of Circulating Tumor Cells. Cancer Research. 65(12). 4993–4997. 268 indexed citations

15.

Loberg, Robert D., Chris K. Neeley, Shawn M. O'Hara, et al.. (2005). Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease. Urology. 65(3). 616–621. 34 indexed citations

16.

Balić, Marija, Nadia Dandachi, Günter Hofmann, et al.. (2005). Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry Part B Clinical Cytometry. 68B(1). 25–30. 106 indexed citations

17.

Cristofanilli, Massimo, G. Thomas Budd, Matthew J. Ellis, et al.. (2004). Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer. New England Journal of Medicine. 351(8). 781–791. 3546 indexed citations breakdown →

18.

Hayes, Daniel M., Baljit Singh, E S Vitetta, et al.. (2002). Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. International Journal of Oncology. 21(5). 1111–7. 134 indexed citations

19.

Moreno, José, Shawn M. O'Hara, Steve Gross, et al.. (2001). Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology. 58(3). 386–392. 123 indexed citations

20.

Wong, Jason K., Robert A. Mustard, D.J. Sadler, et al.. (1999). Predicting Infection in Localized Intraabdominal Fluid Collections: Value of pH and pO2 Measurements. Journal of Vascular and Interventional Radiology. 10(4). 421–427. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact